Artificial Intelligence (AI) is steadily reshaping digital pathology – but not through sudden disruption or autonomous diagnosis. In the U.S. healthcare environment, AI is evolving as a clinically governed, decision-support technology that enhances diagnostic consistency, operational efficiency, and long-term sustainability for pathology laboratories.

Your pathologists are diagnosing cancer. But your billing team? They’re diagnosing something else entirely: denials, und...
read more
U.S. clinical labs face mounting regulatory challenges and shifting payer dynamics that are fundamentally changing how l...
read more
Physician practices face mounting financial pressures from rising operational costs, increasing claim denials, and compl...
read more
Recent federal layoffs have added a new layer of uncertainty for providers impacted by the No Surprises Act. The federal...
read more
The healthcare industry in the United States is undergoing rapid transformation. As 2025 develops, healthcare leaders fa...
read more
At more than 90 million people, Medicaid sits near the top of the list of the United States’ largest insurers. It covers...
read more
The No Surprises Act (NSA) brought with it large amounts of speculation on its impact on physician billing services, and...
read more
Healthcare providers should constantly be reviewing and assessing the performance of their payer contracts....
read more
While COVID-19 “changed everything”, the change hasn’t stopped. Physicians will find that, even as things are settling d...
read more